BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6,...

Clario and PathAI: Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders Strategic Partnership: Streamlined, single-vendor solution improves diagnostic...

MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...

Proscia: Pathology at the Speed of Life Streamlining Clinical Development and Maximizing Trial Success with an Enterprise Pathology Platform October 16 11:00 AM — 11:45 AM EDT Register Join us for an exciting discussion about...

England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably. England’s first centre of its kind is set to make significant improvements in cancer...

Massive Bio: New partnership brings accurate trial recommendations to Azra AI’s national client base of medical systems and hospitals, including leading healthcare providers NEW YORK & FRANKLIN, Tenn.--(BUSINESS WIRE)--Massive Bio, a...